In the dynamic landscape of global biopharmaceutical innovation, two cities stand out as the undisputed leaders shaping the industry’s future: Boston’s Cambridge and San Francisco’s Bay Area. These two clusters have become synonymous with cutting-edge research, massive venture capital investments, and vibrant ecosystems that drive breakthroughs in life sciences. Yet, beneath the impressive statistics, a […]
Tom Spencer